Search

everythinglearnresearchcommunity

for

Search:↓

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Vaniqa cream slows unwanted facial hair growth in women.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

CD101 is highly effective in treating dermatophytosis in guinea pigs.

The MPA-ISO cocrystal improved solubility and dissolution rate, while the others did not.

Drug repositioning offers hope for new, affordable treatments for a genetic skin disorder called ARCI.

Early sunburn treatment with certain inhibitors may reduce skin cancer risk.

Diane and Androcur 10 improved acne and seborrhea in most women, and hirsutism and alopecia in about half.

QR678 Neo® is a safe and effective treatment for hair loss in men and women.

1,2,3,4-tetrahydroquinoline compounds are great for stable, pure blue hair dye.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

A man had a rare skin reaction from a hair loss medication, which improved after stopping the drug.

Clascoterone 1% cream is a promising new treatment for acne.

Hydroxychloroquine and chloroquine are not recommended for COVID-19 treatment due to insufficient evidence and safety concerns.

50-mg ritlecitinib capsules are bioequivalent to 100-mg capsules.

Cinobufacin with chemotherapy improves treatment response and quality of life in advanced breast cancer patients while reducing some side effects.